Navigation Links
Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
Date:5/9/2008

KENILWORTH, N.J., May 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will hold its Annual Meeting of Shareholders Friday, May 16, 2008, in Memphis, Tenn. At 8 a.m. (CDT) (9 a.m. EDT) on that day, a live Webcast of the meeting will be available to all interested parties via the corporate Web site, http://www.schering-plough.com.

At the Annual Meeting, Fred Hassan, Chairman and CEO, will report to shareholders on the company's performance and the progress being achieved toward its long-term goals.

Those wishing to listen live to the Webcast of the Annual Meeting should go to the Investor Relations section of the Schering-Plough corporate Web site, http://www.schering-plough.com, and click on the "Presentations/Webcasts" link. A replay of the Webcast will be available via the Web site later that day.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
2. Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
3. Schering-Plough CEO Buys $2 Million in Common Shares
4. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
5. Schering-Plough Reports Financial Results for First Quarter of 2008
6. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
7. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
8. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
10. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
11. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... 2017  Genisphere LLC, provider of the 3DNA ... collaborative and sponsored research agreement with the University ... The overall goal of the partnership is to ... designs and formulations after in vivo ... vasculature as well as inflammatory responses, demonstrating various ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... & Rehabilitation, P.A. , proudly announced today that acclaimed physiatrist Matthew Terzella, MD, ... on May 15, 2017. , Dr. Terzella completed his residency in Physical Medicine ...
(Date:4/21/2017)... ... April 21, 2017 , ... The 2017 Colorado Manufacturing Awards ... 30 nominees and well as the first-year award for 2017 Manufacturing Women of ... was hosted by CompanyWeek and Manufacturers Edge, among other sponsors. , The ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... to nourishing a range of emerging bio and technology start-ups, is hosting “Celebration ... 2017. This double event will start with libations and networking at 3:30 p.m. ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):